About Cellmid Limited
Cellmid Limited (ASX: CDY) is an Australian biotechnology company developing innovative therapies and diagnostic tests for a number of cancer indications.
Cellmid Limited Description
Cellmid is an Australian biotechnology company with lead drug candidates in immuno-oncology. The Company is developing innovative novel therapies and diagnostic tests for a number of cancer indications, in particular solid tumours. Cellmid holds the largest and most comprehensive portfolio of intellectual property related to the novel oncology target midkine and midkine antagonists globally. The Company’s most advanced development programmes involve using its anti-midkine antibodies in addition to commercialising midkine as a biomarker for the early diagnosis and prognosis of cancer.
For further information please see www. cellmid.com. au